Scholarlink

Retinopathy of prematurity (ROP), one of the leading causes of childhood blindness worldwide, is a vasoproliferative retinal disease characterized by abnormal vascularization in preterm infants. Early-stage ROP is treated with laser and anti-vascular endothelial growth factor (anti-VEGF) injections. However, 25% of treated eyes still develop retinal detachment and severe vision loss in the future.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Retinopathy of Prematurity

  • 章节

  • 发表日期：

    2026年

查看全文
  • Remzi Avcı,
  • Ayşegül Mavi Yıldız,
  • Sami Yılmaz

摘要

Retinopathy of prematurity (ROP), one of the leading causes of childhood blindness worldwide, is a vasoproliferative retinal disease characterized by abnormal vascularization in preterm infants. Early-stage ROP is treated with laser and anti-vascular endothelial growth factor (anti-VEGF) injections. However, 25% of treated eyes still develop retinal detachment and severe vision loss in the future.